AI assistant
MEDIFAST INC — Director's Dealing 2022
Aug 11, 2022
33899_dirs_2022-08-11_c1203f21-6750-426b-aad0-d8c90fb697df.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 4 — Statement of Changes in Beneficial Ownership
Issuer: MEDIFAST INC (MED)
CIK: 0000910329
Period of Report: 2022-08-09
Reporting Person: BROWN JEFFREY J (Director)
Non-Derivative Transactions
| Date | Security | Code | Shares | Price | A/D | Holdings After | Ownership |
|---|---|---|---|---|---|---|---|
| 2022-08-09 | Common Stock | P | 410 | $125.72 | Acquired | 410 | Indirect |
| 2022-08-09 | Common Stock | P | 3530 | $126.63 | Acquired | 3940 | Indirect |
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 2354.040 | Direct |
| Common Stock | 35937.85 | Indirect |
Footnotes
F1: These shares are directly owned by Brown Equity Partners, LLC, for which the reporting person is the managing member.
F2: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $125.57 to $125.90, inclusive. The reporting person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares acquired at each separate price within the ranges set forth in footnotes 2 and 3 herein.
F3: The price reported in Column 4 is a weighted average price. These shares were acquired in multiple transactions at prices ranging from $126.11 to $126.96, inclusive.
F4: These shares are directly owned by Jeffrey Brown Living Trust, for which the reporting person is the sole trustee and sole beneficiary.